The Michigan Supreme Court ruled July 31 that the state’s attorney general may continue pursuing an investigation into Eli Lilly’s insulin pricing practices under the Michigan Consumer Protection Act, reversing lower court rulings that had blocked the case. In a…

An FDA advisory committee voted 10-3 July 30 that efficacy results from Replimune’s study for RP1 were evaluable and clinically meaningful, advancing the company’s application for the experimental melanoma therapy after the FDA rejected it twice. The Cellular, Tissue, and…

Morgantown, W.Va.-based WVU Medicine has opened the WVUH Community Pharmacy, expanding access to pharmacy services for residents, patients, students and employees. The pharmacy is integrated with the health system’s community pharmacy network, allowing pharmacy staff to work directly with providers…

Active U.S. drug shortages increased to 227 in the second quarter of 2026, marking the third consecutive quarterly increase, according to the American Society of Health-System Pharmacists. Nearly half of all new shortages this year involve medications made by a…

Health system pharmacies face mounting pressure to improve medication safety while managing workforce shortages and growing regulatory requirements. Reducing variation in sterile compounding is a key step towards this end. As the complexity and volume of compounded medications continues to…

Drugmakers have pushed back their resupply estimates for carboplatin, one of four chemotherapy drugs in a monthslong shortage, with some formulations now not expected to return until 2027. Cisplatin, carboplatin, oxaliplatin and ifosfamide, which form the backbone of treatment for…

The Health Resources and Services Administration has revised its 340B Rebate Model Pilot Program, establishing a voluntary pathway for qualifying drug manufacturers to provide 340B ceiling prices through rebates rather than upfront discounts for a limited group of covered outpatient…

Volatility in global oil markets could significantly increase the cost of manufacturing essential medicines and expose vulnerabilities in pharmaceutical supply chains, according to a July Unitaid report. Here are five things to know:

Polypharmacy was the only higher-risk medication exposure independently associated with increased all-cause mortality among older adults after accounting for drug-drug interactions and potentially inappropriate medications, according to a study published in the Journal of the American Geriatrics Society. Here are…

The University of Kansas School of Pharmacy’s Doctor of Pharmacy program has been placed on “accredited with probation” status by the Accreditation Council for Pharmacy Education after the accreditor identified deficiencies in experiential learning, student services, faculty staffing, governance and…